SK
Shridhara Kela
About Shridhara Kela
Data last updated:
Shridhara Kela is a Director at Tenshi Pharmaceuticals Private Limited (since 2024), Partner at Devicam Capital Llp (since 2025) and Partner at Tenshi Ventures Llp (since 2025), and holds 1 more current directorship. The companies operate in Financial Services, Business Outsourcing and Pharma. The largest current company by reported revenue is Tenshi Pharmaceuticals Private Limited at ₹1,071 Cr (FY 2024). Earlier, Shridhara Kela was a Director at Serovia Pharma Private Limited (2025) and Director at Sequent Research Limited (2012–2015) and 12 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tenshi Pharmaceuticals Private Limited U70200KA2016PTC200180 | Director | 03 Jun 2024 | 2016 | ₹1,071 Cr (FY 2024) | Active |
 Devicam Capital Llp AAB-9882 | Partner | 26 Mar 2025 | 2014 | Active | |
| Tenshi Ventures Llp AAC-2127 | Partner | 20 Aug 2025 | 2014 | Active | |
| Qualichem Specialties Private Limited U24231TZ2008PTC014912 | Director | 31 Mar 2015 | 2008 | Under Process Of Striking Off |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Serovia Pharma Private Limited U21001KA2025PTC205529 | Director | 19 Jul 2025 | 2025 | Active | |
 Sequent Research Limited U24232TS2007PLC196886 | Director | 28 Dec 2012 | 2007 | ₹9.52 Cr (FY 2025) | Amalgamated |
| Quest Healthcare Private Limited U24246KA2005PTC035617 | Director | 27 Dec 2012 | 2005 | ₹1.31 Cr (FY 2025) | Active |
| Elysian Life Sciences Private Limited U24232KA2010PTC052742 | Director | 25 May 2011 | 2010 | Strike Off | |
 Elysian Health Care Private Limited U24230KA2010PTC053004 | Director | 01 Dec 2011 | 2010 | ₹7.84 Cr (FY 2025) | Active |
| Sequent Anti Biotics Private Limited U24230KA2010PTC053487 | Director | 04 May 2010 | 2010 | Strike Off | |
| Sequent Pharmaceuticals Private Limited U24230KA2010PTC053584 | Director | 11 May 2010 | 2010 | Strike Off | |
| Sequent Penems Private Limited U24233KA2010PTC053548 | Director | 10 May 2010 | 2010 | ₹70.9 Lakh (FY 2025) | Active |
| Netequity Ventures Private Limited U06592KA1999PTC026028 | Director | 11 Mar 2009 | 1999 | Amalgamated | |
| Caryl Pharma Private Limited U24230KA1986PTC007632 | Additional Director | 11 Mar 2009 | 1986 | Amalgamated | |
| Sequent Specialty Chemicals Private Limited U24230KA2009PTC051060 | Director | 04 Jun 2012 | 2009 | Dissolved (Liquidated) | |
| Taitai Restaurants Private Limited U55101KA2005PTC037479 | Director | 15 Sep 2011 | 2005 | Strike Off | |
| Vedic Elements Private Limited U73100KA1999PTC026027 | Additional Director | 02 Oct 2009 | 1999 | Amalgamated | |
| Latitude Projects Private Limited U74210KA2006PTC038781 | Director | 15 Sep 2011 | 2006 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shridhara Kela
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pudhucode Radhakrishnan Kannan | 03435209 | Tenshi Pharmaceuticals Private Limited | Director |
| Akila Chandrashekar Raju | 07590312 | Devicam Capital Llp | Partner |
| Chandrappa Seetharamaiah | 07405773 | Devicam Capital Llp , Tenshi Ventures Llp | Designated Partner |
| Ramaprasad Jyothinagaravyasha Sriraman | 00173696 | Devicam Capital Llp , Tenshi Ventures Llp | Designated Partner |
| Nilesh Khushalchand Doshi | 00436059 | Qualichem Specialties Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shridhara Kela
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shridhara Kela
Shridhara Kela currently holds 4 directorships: Tenshi Pharmaceuticals Private Limited (Director, since 03 Jun 2024, revenue ₹1,071 Cr (FY 2024)); Devicam Capital Llp (Partner, since 26 Mar 2025); Tenshi Ventures Llp (Partner, since 20 Aug 2025); Qualichem Specialties Private Limited (Director, since 31 Mar 2015).
Shridhara Kela was first appointed on 11 Mar 2009 as Director at Netequity Ventures Private Limited. The most recent appointment on record is 20 Aug 2025 at Tenshi Ventures Llp.
Shridhara Kela held 14 earlier board appointments: Serovia Pharma Private Limited (Director, 19 Jul 2025 to 24 Oct 2025); Sequent Research Limited (Director, 28 Dec 2012 to 10 Aug 2015); Quest Healthcare Private Limited (Director, 27 Dec 2012 to 16 Jun 2014); Elysian Life Sciences Private Limited (Director, 25 May 2011 to 10 May 2017); Elysian Health Care Private Limited (Director, 01 Dec 2011 to 11 Jun 2013); and 9 more.
The current boards of Shridhara Kela's companies include Pudhucode Radhakrishnan Kannan (Tenshi Pharmaceuticals Private Limited), Akila Chandrashekar Raju (Devicam Capital Llp), Chandrappa Seetharamaiah (Devicam Capital Llp), Ramaprasad Jyothinagaravyasha Sriraman (Devicam Capital Llp), Nilesh Khushalchand Doshi (Qualichem Specialties Private Limited).